Works matching AU LEE, MOON-KYU


Results: 64
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus.

    Published in:
    Journal of Diabetes Investigation, 2010, v. 1, n. 4, p. 143, doi. 10.1111/j.2040-1124.2010.00023.x
    By:
    • Cho, Young Min;
    • Koo, Bo Kyung;
    • Son, Ho Young;
    • Lee, Kwang Woo;
    • Son, Hyun Shik;
    • Choi, Dong Seop;
    • Kim, Bo Wan;
    • Kim, Yong Ki;
    • Lee, Moon Kyu;
    • Lee, Hyun Chul;
    • Min, Kyung Wan;
    • Chung, Min Young;
    • Baek, Hong Sun;
    • Kim, Youngkun;
    • Yoo, Hyung Joon;
    • Park, Kyong Soo;
    • Lee, Hong Kyu
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Subclinical thyroid dysfunction and risk of carotid atherosclerosis.

    Published in:
    PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0182090
    By:
    • Kim, Hosu;
    • Kim, Tae Hyuk;
    • Kim, Hye In;
    • Park, So Young;
    • Kim, Young Nam;
    • Kim, Seonwoo;
    • Kim, Min-Ji;
    • Jin, Sang-Man;
    • Hur, Kyu Yeon;
    • Kim, Jae Hyeon;
    • Lee, Moon-Kyu;
    • Min, Yong-Ki;
    • Chung, Jae Hoon;
    • Kang, Mira;
    • Kim, Sun Wook
    Publication type:
    Article
    24
    25
    26

    Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial 接受基础胰岛素优化治疗之后需要胰岛素强化治疗的患者使用基础-餐时胰岛素治疗与使用预混胰岛素治疗的对照试验:一项为期24周的随机非劣性试验

    Published in:
    Journal of Diabetes, 2016, v. 8, n. 3, p. 405, doi. 10.1111/1753-0407.12312
    By:
    • Jin, Sang ‐ Man;
    • Kim, Jae Hyeon;
    • Min, Kyung Wan;
    • Lee, Ji Hyun;
    • Ahn, Kue Jeong;
    • Park, Jeong Hyun;
    • Jang, Hak Chul;
    • Park, Seok Won;
    • Lee, Kwan Woo;
    • Won, Kyu Chang;
    • Kim, Young ‐ Il;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Lee, Jee ‐ Hyun;
    • Lee, Moon ‐ Kyu
    Publication type:
    Article
    28
    29
    30

    A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

    Published in:
    Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 295, doi. 10.1002/dmrr.2613
    By:
    • Jung, Chang Hee;
    • Park, Cheol‐Young;
    • Ahn, Kyu‐Joeng;
    • Kim, Nan‐Hee;
    • Jang, Hak‐Chul;
    • Lee, Moon‐Kyu;
    • Park, Joong‐Yeol;
    • Chung, Choon‐Hee;
    • Min, Kyung‐Wan;
    • Sung, Yeon‐Ah;
    • Park, Jeong‐Hyun;
    • Kim, Sung Jin;
    • Lee, Hyo Jung;
    • Park, Sung‐Woo
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic function.

    Published in:
    Journal of Cardiovascular Imaging, 2025, v. 33, n. 1, p. 1, doi. 10.1186/s44348-024-00043-0
    By:
    • Jeon, Kina;
    • Jang, Shin Yi;
    • Lee, You-Bin;
    • Kim, Jihoon;
    • Kim, Darae;
    • Chang, Sung-A;
    • Park, Sung-Ji;
    • Lee, Sang-Chol;
    • Park, Seung Woo;
    • Lee, Moon-Kyu;
    • Kim, Eun Kyoung;
    • Hur, Kyu Yeon
    Publication type:
    Article
    37
    38
    39
    40
    41

    Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study).

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1527, doi. 10.1111/dom.14061
    By:
    • Kim, Gyuri;
    • Lim, Soo;
    • Kwon, Hyuk‐Sang;
    • Park, Ie B.;
    • Ahn, Kyu J.;
    • Park, Cheol‐Young;
    • Kwon, Su K.;
    • Kim, Hye S.;
    • Park, Seok W.;
    • Kim, Sin G.;
    • Moon, Min K.;
    • Kim, Eun S.;
    • Chung, Choon H.;
    • Park, Kang S.;
    • Kim, Mikyung;
    • Chung, Dong J.;
    • Lee, Chang B.;
    • Kim, Tae H.;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    42

    Efficacy and safety of gemigliptin as add‐on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study).

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 1, p. 123, doi. 10.1111/dom.13873
    By:
    • Cho, Young Min;
    • Deerochanawong, Chaicharn;
    • Seekaew, Samroeng;
    • Suraamornkul, Swangjit;
    • Benjachareonwong, Sunun;
    • Sattanon, Sarinya;
    • Chamnan, Parinya;
    • Sirirak, Thanitha;
    • Kosachunhanun, Natapong;
    • Pratipanawatr, Thongchai;
    • Suwanwalaikorn, Sompongse;
    • Lee, Woo Je;
    • Kim, Sungrae;
    • Choi, Seonghui;
    • Kang, Eun Seok;
    • Oh, Taekeun;
    • Kwon, Sam;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    43
    44

    Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2408, doi. 10.1111/dom.13394
    By:
    • Han, Kyung‐ah;
    • Chon, Suk;
    • Chung, Choon Hee;
    • Lim, Soo;
    • Lee, Kwan‐woo;
    • Baik, Seihyun;
    • Jung, Chang Hee;
    • Kim, Dong‐sun;
    • Park, Kyong Soo;
    • Yoon, Kun‐ho;
    • Lee, In‐kyu;
    • Cha, Bong‐soo;
    • Sakatani, Taishi;
    • Park, Sumi;
    • Lee, Moon‐kyu
    Publication type:
    Article
    45

    Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial ( INICOM study).

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 87, doi. 10.1111/dom.12787
    By:
    • Lim, Soo;
    • Han, Kyung Ah;
    • Yu, JaeMyung;
    • Chamnan, Parinya;
    • Kim, Eun Sook;
    • Yoon, Kun‐Ho;
    • Kwon, Sam;
    • Moon, Min Kyong;
    • Lee, Kwan Woo;
    • Kim, Dong‐Jun;
    • Kim, Mikyung;
    • Wongtanate, Manaj;
    • Kim, Eun Young;
    • Kim, Sung‐Ho;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    46
    47
    48

    Hormetic effect of triiodothyronine in metabolically healthy obese persons.

    Published in:
    Endocrine (1355008X), 2017, v. 57, n. 3, p. 418, doi. 10.1007/s12020-017-1363-9
    By:
    • Eun Jun, Ji;
    • Hyuk Kim, Tae;
    • Lee, Seung-Eun;
    • Lee, You-Bin;
    • Hwan Jee, Jae;
    • Cheol Bae, Ji;
    • Jin, Sang-Man;
    • Yeon Hur, Kyu;
    • Hyeon Kim, Jae;
    • Wook Kim, Sun;
    • Hoon Chung, Jae;
    • Min, Yong-Ki;
    • Lee, Moon-Kyu
    Publication type:
    Article
    49
    50